| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 08/10/2005 | EP1181277A4 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| 08/10/2005 | CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases |
| 08/10/2005 | CN1653043A Method for the production of sulphamic acid halogenides |
| 08/10/2005 | CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 08/10/2005 | CN1653037A Substituted tetracycline compounds |
| 08/10/2005 | CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/10/2005 | CN1652777A Combination of organic compounds |
| 08/10/2005 | CN1651428A Preparation method of hydrobromic acid antifebrile dichroanone |
| 08/10/2005 | CN1651413A Synthesis method of single optical isomer nitrendipine |
| 08/10/2005 | CN1213995C Method for the production of esters of unsaturated carboxylic acids |
| 08/09/2005 | US6927295 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 08/09/2005 | US6927294 Nitrogen-containing heterocycles |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 08/09/2005 | CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 08/04/2005 | WO2005070877A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | WO2005070133A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
| 08/04/2005 | WO2005069834A2 4-aryl piperidines |
| 08/04/2005 | WO2005018557A3 Substituted pyridinones |
| 08/04/2005 | US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders |
| 08/04/2005 | US20050171353 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5) |
| 08/04/2005 | US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/04/2005 | US20050171159 Synthesis of (4-bromophenyl)(4-piperidy)methanone-(Z)-O-ethyloxime and salts |
| 08/04/2005 | US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders |
| 08/04/2005 | US20050171157 Substituted piperidines |
| 08/04/2005 | US20050171156 Prodrugs of potassium channel inhibitors |
| 08/04/2005 | US20050171155 Method to separate stereoisomers |
| 08/04/2005 | US20050171154 Carboxylic acid amides |
| 08/04/2005 | US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 08/04/2005 | US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy |
| 08/04/2005 | US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders |
| 08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/04/2005 | US20050171102 Semicarbazide derivatives for combating thromboembolic diseases |
| 08/04/2005 | US20050171098 MCH antagonists and their use in the treatment of obesity |
| 08/04/2005 | US20050171097 aryl is nitrogen heterocycyl; highly effective at a low dose and excellent in safety; farm and garden pests; 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 08/04/2005 | US20050171082 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | US20050171078 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 08/04/2005 | US20050171062 Administering to an animal having ocular hypertension or inflammatory bowel disease a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester |
| 08/04/2005 | US20050171061 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 08/04/2005 | CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | CA2553242A1 2,6-disubstituted piperidines as modulators of chemokine receptor activity |
| 08/04/2005 | CA2552362A1 4-aryl piperidines |
| 08/03/2005 | EP1559707A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 08/03/2005 | EP1559428A1 Receptor regulator |
| 08/03/2005 | EP1558606A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 08/03/2005 | EP1558599A2 Heteroarylpiperidine modulators of chemokine receptor activity |
| 08/03/2005 | EP1558594A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2005 | EP1558577A2 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors |
| 08/03/2005 | EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2005 | EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 08/03/2005 | EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 08/03/2005 | EP1558250A1 Gamma-aminoamide modulators of chemokine receptor activity |
| 08/03/2005 | EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/03/2005 | EP1436284B1 Synthesis of 4- (z)-(4-bromophenyl)(ethoxyimino)methyl]-1'- 2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 08/03/2005 | CN1649884A Novel azacyclic ethynyl derivatives |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649845A Muscarinic antagonists |
| 08/03/2005 | CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient |
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1649820A Compounds that modulate PPAR activity and methods for their preparation |
| 08/03/2005 | CN1649589A The treatment of pain with ifendropil |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213030C Inhibition of polymerization of unsaturated monomers |
| 08/03/2005 | CN1213029C S-Ht receptor agonist and its preparing method for salt |
| 08/03/2005 | CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/02/2005 | US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 08/02/2005 | US6924374 Modulators of dopamine neurotransmission |
| 08/02/2005 | US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 08/02/2005 | US6924286 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 08/02/2005 | CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/28/2005 | WO2005068466A1 Compounds useful in therapy |
| 07/28/2005 | WO2005068461A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 07/28/2005 | WO2005068448A1 Sulfonamides antagonising n-type calcium channels |
| 07/28/2005 | WO2005068427A1 Carboxamide derivative and use thereof |
| 07/28/2005 | WO2005068426A1 Piperidine derivatives as gcs inhibitors |
| 07/28/2005 | WO2005068415A1 Phenylalanine derivative |
| 07/28/2005 | WO2005032490A3 Cyclic diamines and derivatives as factor xa inhibitors |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165057 cholesterol acyl transferase inhibitor for treatment of hyperlipidemia and atherosclerosis; piperidin-4-yl]methyl urea derivatives |
| 07/28/2005 | US20050165056 salt formation; polymorph forms or amorphous forms; antihistamines, antiallergens, bronchodilator agent |
| 07/28/2005 | US20050165037 Process for producing cyclic thioether and synthetic intermediate thereof |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165014 1 4-dihydro-1 4-diphenylpyridine derivatives |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050164990 Piperidinyl prostaglandin e analogs |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |